Is REGN up or down today?
REGN is up 0.75% today, last at 700.40. This stock moved +0.75% versus the prior close.
REGN · Regeneron Pharmaceuticals
REGN (Regeneron Pharmaceuticals) is trading at 700.40, up 0.75% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 28 headlines skew mixed. Earnings and M&A themes dominated coverage. Stories with measurable price impact averaged +7.56% — the market reacted positively.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
REGN is up 0.75% today, last at 700.40. This stock moved +0.75% versus the prior close.
Over the past 7 days, 28 headlines skew mixed. Earnings and M&A themes dominated coverage. Stories with measurable price impact averaged +7.56% — the market reacted positively. Dominant story: REGN Court Deadline: Regeneron Investor Deadline in - GlobeNewswire (1 source, neutral) RSI is 66 — leaning bullish Price above 50-day average — short-term uptrend Social (demo): 40% of recent mentions lean bullish — social mood is cautious.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 12,797 mentions over 30d
REGN Court Deadline: Regeneron Investor Deadline in - GlobeNewswire
Regeneron (REGN) To Report Earnings Tomorrow: Here Is What To Expect - TradingView
Regeneron (REGN) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Kiniksa tops Q2 estimates on Regeneron-partnered Arcalyst